Target intelligence / Profile preview

PMS1 protein homolog 1 (PMS1)

Target
PMS1
Molecular classification
DNA mismatch repair protein, MutL family protein, ATPase, DNA-binding protein
01

Overview

PMS1 protein homolog 1 is a member of the MutL homolog family and a critical component of the DNA mismatch repair (MMR) pathway, which maintains genomic integrity by correcting base-pair mismatches and insertion-deletion loops during DNA replication [1, 2]. It typically functions as a heterodimer with MLH1, forming the MutL-beta complex [1, 6]. Mutations in the PMS1 gene are linked to hereditary non-polyposis colorectal cancer type 3 (HNPCC3), also known as Lynch syndrome, which predisposes individuals to early-onset colorectal and extra-colonic malignancies [10, 16]. Beyond its role in cancer, PMS1 has recently been identified as a key genetic modifier in Huntington's disease and other triplet repeat expansion disorders [7, 12]. It promotes the somatic expansion of CAG repeats, a process that accelerates disease onset and progression [14]. Consequently, PMS1 is being explored as a therapeutic target; small molecule splice modulators like SKY-0515 and branaplam are designed to reduce PMS1 levels to slow repeat expansion and neurodegeneration [12, 14]. However, therapeutic inhibition of PMS1 must be carefully managed to avoid compromising overall DNA repair capacity and increasing the risk of secondary cancers [14].

Other names
PMS1HNPCC3MLH2PMSL1DNA mismatch repair protein PMS1PMS1 postmeiotic segregation increased 1 (S. cerevisiae)Mismatch repair system componenthMLH2hPMS1
02

Mechanism of action

Splice modulation to reduce protein expression via pseudoexon inclusion

03

Biological functions

DNA mismatch repairMaintenance of genomic integrityATP hydrolysisDNA damage responseDNA binding
04

Disease associations

Lynch syndrome (HNPCC type 3)Colorectal cancerHuntington's diseaseTriplet repeat expansion diseasePancreatic ductal adenocarcinomaOral squamous cell carcinoma
05

Safety considerations

Potential for increased genomic instabilityIncreased risk of secondary malignancies due to MMR deficiencyOff-target effects of splice modulators
06

Interacting drugs

Branaplam

2 more in the full profile.

07

Biomarkers

Microsatellite instability (MSI)Somatic CAG repeat expansion ratePMS1 protein expression levels

Beyond the preview

Go deeper on PMS1 protein homolog 1 (PMS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PMS1 protein homolog 1 (PMS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call